StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) operating KPIs

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)

Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%

Johnson & Johnson diabetes Care Franchise [divested FY2018–FY2019] — U.S. sales ($M) ($M)

Form 10-Q / 10-K Segment Note & Form 8-K EX-99.2 Segment Sales Schedule

Latest, Q4 2019
0
Period ended Dec 29, 2019
Change on a year earlier
–
0 in Q4 2018
History
12 quarters
Since Q1 2017
Sources
9
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedDiabetes Care Franchise [divested FY2018–FY2019] — U.S. sales ($M) ($M)Year on yearSource
Q4 2019Dec 29, 20190–Form 10-K (filed 2020-02-18) ↗
Q3 2019Sep 29, 20190-100.0%Form 10-Q (filed 2019-10-28) ↗
Q2 2019Jun 30, 20190-100.0%Form 10-Q (filed 2019-07-29) ↗
Q1 2019Mar 31, 20190-100.0%Form 10-Q (filed 2019-05-01) ↗
Q4 2018Dec 30, 20180-100.0%Form 10-K (filed 2021-02-22) ↗
Q3 2018Sep 30, 2018125-25.6%Form 10-Q (filed 2018-10-31) ↗
Q2 2018Jul 1, 2018129-19.4%Form 10-Q (filed 2018-08-02) ↗
Q1 2018Apr 1, 2018117-24.0%Form 10-Q (filed 2019-05-01) ↗
Q4 2017Dec 31, 2017130–Form 10-K (filed 2019-02-20) ↗
Q3 2017Oct 1, 2017168–Form 10-Q (filed 2018-10-31) ↗
Q2 2017Jul 2, 2017160–Form 10-Q (filed 2018-08-02) ↗
Q1 2017Apr 2, 2017154–Form 10-Q (filed 2018-05-01) ↗

Cite this data

StockData. (2026). Johnson & Johnson Diabetes Care Franchise [divested FY2018–FY2019] — U.S. sales ($M) ($M), quarterly Q1 2017–Q4 2019 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/mt_diabetes_legacy_us

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.